These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 18476419)

  • 1. [Effect of treatment for myelodysplastic syndrome by Qinghuang Powder combined with Chinese herbs for reinforcing shen and strenghening pi].
    Xu S; Hu XM; Xu YG
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2008 Mar; 28(3):216-8. PubMed ID: 18476419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of Qinghuang Powder combined Chinese herbs for Pi-strengthening and Shen-reinforcing on HIF-1alpha in bone marrow mononuclear cells of myelodysplastic syndrome patients: an experimental research].
    Gao F; Xu YG; Yang XH; Ma R
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2014 Feb; 34(2):174-8. PubMed ID: 24672941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical observation of the treatment of myelodysplastic syndrome mainly with Qinghuang Powder.
    Xu S; Ma R; Hu XM; Xu YG; Yang XH; Wang HZ; Sun SZ; Liu F
    Chin J Integr Med; 2011 Nov; 17(11):834-9. PubMed ID: 22057412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of treatment for hypocellular myelodysplastic syndromes by a low dose qinghuang powder combined with Chinese drugs for Shen supplementing and Pi invigorating: a clinical observation].
    Zhou QB; Wang HZ; Gao F; Tang XD; Xu S; Yang XH; Xu YG; Hu XM; Ma R
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2014 Dec; 34(12):1444-8. PubMed ID: 25632743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical observation on treatment of myelodysplastic syndromes with yisuikang].
    Guo PJ; Li GZ; Liu PL
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 1995 Feb; 15(2):74-6. PubMed ID: 7787394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of qinghuang power combined Chinese herbs for shen reinforcing and Pi strengthening on activated T cells of myelodysplastic syndrome patients].
    Gao F; Ma R; Yang XH; Xu YG
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2013 Apr; 33(4):443-7. PubMed ID: 23841258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of TCM syndrome-typing based therapy combined with cyclosporin in treating myelodysplastic syndrome].
    Liu L; Shu X; Hu NP
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2006 Oct; 26(10):933-5. PubMed ID: 17121049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of myelodysplastic syndrome by combined traditional Chinese medicine and Western medicine therapy].
    Wang XT; He HT
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 1993 Jul; 13(7):410-2, 388. PubMed ID: 8251723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Qinghuang Powder () Combined with Bupi Yishen Decoction () in Treating Patients with Refractory Cytopenia with Multilineage Dysplasia through Regulating DNA Methylation.
    Zhou QB; Yang XH; Wang HZ; Wang DX; Xu YG; Hu XM; Xu FQ; Ma R
    Chin J Integr Med; 2019 May; 25(5):354-359. PubMed ID: 29500545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Analysis on the prognostic factors in patients with large hepatocarcinoma treated by shentao ruangan pill and hydroxycamptothecine].
    Lin LZ; Zhou DH; Liu K; Wang FJ; Lan SQ; Ye XW
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2005 Jan; 25(1):8-11. PubMed ID: 15719740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Efficiency of benazepril combined with wind dispelling and dampness removing chinese herbs on stage 3 chronic kidney disease with wind-dampness syndrome: a prospective study].
    Fang YQ; Lu Y; Wang YJ
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2012 Mar; 32(3):311-6. PubMed ID: 22686073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Exploration of academic thoughts on treating myelodysplastic syndrome with combination of disease and syndrome by Prof. Ma Rou].
    Gao F; Xu S; Sun SZ; Hu XM; Ma R
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2013 Mar; 33(3):401-3. PubMed ID: 23713259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of oligospermia/asthenozoospermia patients by three different Chinese medical principles: a randomized control clinical study].
    Guo J; Wang F; Zhang Q; Geng Q; Yu GJ; Zhao JY; Gao QH; Song CS
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2013 Sep; 33(9):1170-3. PubMed ID: 24273967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relation of Blood Arsenic Concentration with Effect and Safety of Arsenic-Containing Qinghuang Powder () in Patients with Myelodysplastic Syndrome.
    Deng ZY; Zhu SR; Wang MJ; Fang S; Zhao P; Zhu QZ; Wang HZ; Guo XQ; Xu YG; Yi BW; Shang XH; Ma R; Hu XM
    Chin J Integr Med; 2019 Jul; 25(7):497-501. PubMed ID: 31278627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The application of a new prognostic score system for 435 cases of primary myelodysplastic syndrome diagnosed with WHO classification].
    Wang XQ;
    Zhonghua Nei Ke Za Zhi; 2009 Aug; 48(8):633-7. PubMed ID: 19954053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Electrophysiological changes in diabetic peripheral neuropathy patients of different Chinese medicine syndrome types intervened by naoxintong and mecobalamin].
    Huang PJ; Mao XH; Wang YP
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2011 Aug; 31(8):1051-6. PubMed ID: 21910333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Long-term effects of androgen combined with low dose all-trans-retinoic acid on myelodysplastic syndrome: follow-up of 60 cases].
    Guan M; Chen SC; Ge CW
    Zhonghua Yi Xue Za Zhi; 2009 Apr; 89(13):919-22. PubMed ID: 19671296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Gene Mutations with Response to Arsenic-Containing Compound Qinghuang Powder () in Patients with Myelodysplastic Syndromes.
    Zhao P; Liang JB; Deng ZY; Wang MJ; Qin JY; Chen CJ; Hu XM
    Chin J Integr Med; 2019 Jun; 25(6):409-415. PubMed ID: 29619748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [An analysis of prognostic factors in 80 myelodysplastic syndrome].
    Xu XQ; Wang JM; Lu SQ; Chen L; Yang JM; Zhang WP; Song XM; Xu YQ; Gong SL; Hou J; Ni X
    Zhonghua Xue Ye Xue Za Zhi; 2008 Nov; 29(11):723-7. PubMed ID: 19176004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical trial on treatment of Parkinson's disease of Gan-Shen yin deficiency type by recipe for nourishing Gan-Shen].
    Zhao H; Li WW; Gao JP
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2007 Sep; 27(9):780-4. PubMed ID: 17969886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.